The present study confirms the dissemination of metallo- β-lactamase (MBL) genes among multi-drug resistant Pseudomonas aeruginosa. Early recognition of MBL producers is important and necessitates rigorous infection control measures and restricted use of carbapenems for treatment of clinical infections. The dissemination of this gene to clinically relevant species may endanger patients and it may have adverse implications on treatment.